News-United Well Technologies Limited

Language

EN CN

Home · News & Events

Industry Information

Radiopharma Has a Dosing Problem: The Amount Injected Is Not Necessarily the Dose the Tumor Gets

A New FAPI Tracer Found 99% of Metastases in Radioiodine-Refractory Thyroid Cancer

A New Kidney Cancer Theranostic Reached Humans. The Tumor Target Worked—But the Stomach Became the Problem.

After Brain Radiation, MRI Can Struggle to Tell Recurrence From Treatment Effect. Radiopharm Wants PET to Solve It.

Stop Telling Me How Much Actinium-225 You Can Make. Tell Me How Much I Can Buy.

Radiopharma Wants Personalized Dosing. First It Needs Everyone to Measure Dose the Same Way

1 2 3 4 5 6 7 ...